Premium
Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
Author(s) -
Wang HanCheng,
Hsieh Yoloung
Publication year - 2001
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.1133
Subject(s) - apomorphine , neuroleptic malignant syndrome , haloperidol , medicine , anesthesia , creatine kinase , dopaminergic , dopamine
A 20‐year‐old psychiatric patient receiving haloperidol treatment developed acute‐onset fever, rigidity, and mental changes. Subcutaneous apomorphine was given alone for treatment. The patient had rapid clinical improvement after the treatment. Serial blood examinations showed decline and subsequent normalization of the creatine phosphokinase levels.